Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients

Immunology Letters

Volumn 141, Issue 2, 2012, Pages 181-189

  Chung, Byung Ha ^a   Kim, Kyoung Woon ^a,b   Sun, In O ^a   Choi, Sun Ryoung ^a   Park, Hoon Suk ^a   Jeon, Eun Joo ^a,b   Kim, Bo Mi ^a,b   Choi, Bum Soon ^a   Park, Cheol Whee ^a   Kim, Yong Soo ^a   Cho, Mi La ^a,b   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

End stage renal disease; Hemodialysis; Memory cells; T helper cells

Indexed keywords

CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 17;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CENTRAL MEMORY T LYMPHOCYTE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EFFECTOR CELL; HEMODIALYSIS; HUMAN; HUMAN CELL; IMMUNE DYSREGULATION; IMMUNOMODULATION; KIDNEY FAILURE; MEMORY T LYMPHOCYTE; NAIVE T LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; THERAPY EFFECT; UREMIA;

ADULT; ANTIGENS, CD; CELL SEPARATION; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-17; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; T-LYMPHOCYTE SUBSETS; TH17 CELLS; UP-REGULATION; UREMIA;

EID: 84855953247     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.10.002     Document Type: Article

References (37)

1. Girndt M., Sester U., Sester M., Kaul H., Khler H. Impaired cellular immune function in patients with end-stage renal failure. Nephrol Dial Transplant 1999, 14:2807-2810.
2. Tzanno-Martins C., Futata E., Jorgetti V., Duarte A.J. Restoration of impaired T-cell proliferation after parathyroidectomy in hemodialysis patients. Nephron 2000, 84:224-227.
3. Newberry W.M., Sanford J.P. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest 1971, 50:1262-1271.
4. Vanholder R., De Smet R., Hsu C., Vogeleere P., Ringoir S. Uremic toxicity: the middle molecule hypothesis revisited. Semin Nephrol 1994, 14:205-218.
5. Yoon J.W., Gollapudi S., Pahl M.V., Vaziri N.D. Naive and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int 2006, 70:371-376.
6. Vanholder R., Ringoir S., Dhondt A., Hakim R. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991, 39:320-327.
7. Haag-Weber M., Horl W.H. Uremia and infection: mechanisms of impaired cellular host defense. Nephron 1993, 63:125-131.
8. Sarnak M.J., Jaber B.L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000, 58:1758-1764.
9. Meuer S.C., Hauer M., Kurz P., Meyer zum Buschenfelde K.H., Kohler H. Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest 1987, 80:743-749.
10. Girndt M., Kohler H., Schiedhelm-Weick E., Meyer zum Buschenfelde K.H., Fleischer B. T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway. Kidney Int 1993, 44:359-365.
11. Hendrikx T.K., van Gurp E.A., Mol W.M., Schoordijk W., Sewgobind V.D., Ijzermans J.N., et al. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells. Nephrol Dial Transplant 2009, 24:1969-1978.
12. Beaman M., Michael J., MacLennan I.C., Adu D. T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure. Nephrol Dial Transplant 1989, 4:216-221.
13. Zhang J., Hua G., Zhang X., Tong R., Du X., Li Z. Regulatory T cells/T-helper cell 17 functional imbalance in uraemic patients on maintenance haemodialysis: a pivotal link between microinflammation and adverse cardiovascular events. Nephrology (Carlton) 2010, 15:33-41.
14. Girndt M., Sester M., Sester U., Kaul H., Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 2001, 78:S206-S211.
15. Yoon J.W., Pahl M.V., Vaziri N.D. Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int 2007, 71:167-172.
16. Taleb S., Tedgui A., Mallat Z. Adaptive T cell immune responses and atherogenesis. Curr Opin Pharmacol 2010, 10:197-202.
17. Brenner B.M. Brenner and Rector's the kidney 2004, Saunders, Philadelphia. 7th ed.
18. Alvarez-Lara M.A., Carracedo J., Ramirez R., Martin-Malo A., Rodriguez M., Madueno J.A., et al. The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset. Nephrol Dial Transplant 2004, 19:3084-3090.
19. Kaul H., Girndt M., Sester U., Sester M., Kohler H. Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease. Am J Kidney Dis 2000, 35:611-616.
20. Meier P., von Fliedner V., Markert M., van Melle G., Deppisch R., Wauters J.P. One-year immunological evaluation of chronic hemodialysis in end-stage renal disease patients. Blood Purif 2000, 18:128-137.
21. Meier P., Dayer E., Ronco P., Blanc E. Dysregulation of IL-2/IL-2R system alters proliferation of early activated CD4+ T cell subset in patients with end-stage renal failure. Clin Nephrol 2005, 63:8-21.
22. Kolls J.K., Linden A. Interleukin-17 family members and inflammation. Immunity 2004, 21:467-476.
23. Turner J.E., Paust H.J., Steinmetz O.M., Panzer U. The Th17 immune response in renal inflammation. Kidney Int 2010, 77:1070-1075.
24. Csiszar A., Ungvari Z. Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease. Med Hypotheses 2004, 63:696-698.
25. Hertel J., Kimmel P.L., Phillips T.M., Bosch J.P. Eosinophilia and cellular cytokine responsiveness in hemodialysis patients. J Am Soc Nephrol 1992, 3:1244-1252.
26. Libetta C., Rampino T., Dal Canton A. Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis 2001, 38:286-295.
27. Davenport P., Tipping P.G. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003, 163:1117-1125.
28. Andrew D.P., Chang M.S., McNinch J., Wathen S.T., Rihanek M., Tseng J., et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J Immunol 1998, 161:5027-5038.
29. Bonecchi R., Bianchi G., Bordignon P.P., Dàmbrosio D., Lang R., Borsatti A., et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1T helper cells (Th1s) and Th2s. J Exp Med 1998, 187:129-134.
30. Sallusto F., Mackay C.R., Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997, 277:2005-2007.
31. Zingoni A., Soto H., Hedrick J.A., Stoppacciaro A., Storlazzi C.T., Sinigaglia F., et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998, 161:547-551.
32. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007, 8:639-646.
33. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
34. Gupta S., Bi R., Su K., Yel L., Chiplunkar S., Gollapudi S. Characterization of naive, memory and effector CD8+ T cells: effect of age. Exp Gerontol 2004, 39:545-550.
35. Meier P., Dayer E., Blanc E., Wauters J.P. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol 2002, 13:204-212.
36. Moser B., Roth G., Brunner M., Lilaj T., Deicher R., Wolner E., et al. Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun 2003, 308:581-585.
37. Ireland D.D., Stohlman S.A., Hinton D.R., Atkinson R., Bergmann C.C. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J Virol 2008, 82:300-310.